Killing of Aspergillus fumigatus by Alveolar Macrophages Is Mediated by Reactive Oxidant Intermediates

ABSTRACT Phagocytosis and mechanisms of killing of Aspergillus fumigatus conidia by murine alveolar macrophages (AM), which are the main phagocytic cells of the innate immunity of the lung, were investigated. Engulfment of conidia by murine AM lasts 2 h. Killing of A. fumigatus conidia by AM begins after 6 h of phagocytosis. Swelling of the conidia inside the AM is a prerequisite for killing of conidia. The contributions of NADPH oxidase and inducible nitric oxide synthase to the conidicidal activity of AM were studied using AM from OF1, wild-type and congenic p47phox−/− 129Sv, and wild-type and congenic iNOS−/− C57BL/6 mice. AM from p47phox−/− mice were unable to kill A. fumigatus conidia. Inhibitors of NADPH oxidase that decreased the production of reactive oxidant intermediates inhibited the killing of A. fumigatus without altering the phagocytosis rate. In contrast to NADPH oxidase, nitric oxide synthase does not play a role in killing of conidia. Corticosteroids did not alter the internalization of conidia by AM but did inhibit the production of reactive oxidant intermediates and the killing of A. fumigatus conidia by AM. Impairment of production of reactive oxidant intermediates by corticosteroids is responsible for the development of invasive aspergillosis in immunosuppressed mice.

[1]  Richard B. Johnston,et al.  Chronic Granulomatous Disease: Report on a National Registry of 368 Patients , 2000, Medicine.

[2]  R. Manhães de Castro,et al.  Effect of stress on the production of O(2)(-) in alveolar macrophages. , 2000, Journal of neuroimmunology.

[3]  J. Latgé,et al.  Phagocytosis and Intracellular Fate of Aspergillus fumigatus Conidia in Alveolar Macrophages , 2003, Infection and Immunity.

[4]  S. Balajee,et al.  Early Events in Macrophage Killing ofAspergillus fumigatus Conidia: New Flow Cytometric Viability Assay , 2001, Clinical Diagnostic Laboratory Immunology.

[5]  D. Phillips,et al.  Association of mycoplasma with HIV-1 and HTLV-I in human T lymphocytes. , 1992, AIDS research and human retroviruses.

[6]  V. Kurup,et al.  T Cell Vaccination in Mice with Invasive Pulmonary Aspergillosis1 , 2000, The Journal of Immunology.

[7]  L. Palmberg,et al.  Reaction of human alveolar macrophages to exposure to Aspergillus fumigatus and inert particles. , 1997, Environmental research.

[8]  S. Levitz,et al.  Mechanisms of resistance of Aspergillus fumigatus Conidia to killing by neutrophils in vitro. , 1985, The Journal of infectious diseases.

[9]  J. Latgé,et al.  Aspergillus fumigatus and Aspergillosis , 1999, Clinical Microbiology Reviews.

[10]  I. Maridonneau-Parini,et al.  Inhibition of O2- generation by dexamethasone is mimicked by lipocortin I in alveolar macrophages. , 1989, The Journal of clinical investigation.

[11]  R. M. Castro,et al.  Effect of stress on the production of O2 − in alveolar macrophages , 2000, Journal of Neuroimmunology.

[12]  R. Bellamy.  The natural resistance-associated macrophage protein and susceptibility to intracellular pathogens. , 1999, Microbes and infection.

[13]  M. Château,et al.  Differentiated U937 cells and human monocytes exhibit a differential production of extracellular oxygen species: O2.- excretion versus H2O2 diffusion. , 1996, FEMS immunology and medical microbiology.

[14]  D. Loebenberg,et al.  In Vitro and In Vivo Activities of SCH 56592 (Posaconazole), a New Triazole Antifungal Agent, againstAspergillus and Candida , 2000, Antimicrobial Agents and Chemotherapy.

[15]  U. Kishore,et al.  Binding of pulmonary surfactant proteins A and D to Aspergillus fumigatus conidia enhances phagocytosis and killing by human neutrophils and alveolar macrophages , 1997, Infection and immunity.

[16]  A. Schaffner.  Therapeutic concentrations of glucocorticoids suppress the antimicrobial activity of human macrophages without impairing their responsiveness to gamma interferon. , 1985, The Journal of clinical investigation.

[17]  A. Groll,et al.  Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. , 1996, The Journal of infection.

[18]  Giorgio Gabella,et al.  Killing activity of neutrophils is mediated through activation of proteases by K+ flux , 2002, Nature.

[19]  A. Schaffner,et al.  Comparison of the antimicrobial activity of deactivated human macrophages challenged with Aspergillus fumigatus and Listeria monocytogenes. , 1996, The Journal of infectious diseases.

[20]  C. Dahlgren,et al.  Differentiation of human peripheral blood monocytes to macrophages is associated with changes in the cellular respiratory burst activity , 1992, Cell biochemistry and function.

[21]  E. Brummer,et al.  Protection of bronchoalveolar macrophages by granulocyte-macrophage colony-stimulating factor against dexamethasone suppression of fungicidal activity for Aspergillus fumigatus conidia. , 2001, Medical mycology.

[22]  A. Schaffner,et al.  Killing of Aspergillus spores depends on the anatomical source of the macrophage , 1983, Infection and immunity.

[23]  J. Latgé,et al.  Participation of complement in the phagocytosis of the conidia of Aspergillus fumigatus by human polymorphonuclear cells. , 1992, The Journal of infectious diseases.

[24]  T. Walsh,et al.  Tumor necrosis factor alpha enhances antifungal activities of polymorphonuclear and mononuclear phagocytes against Aspergillus fumigatus. , 1998, Infection and immunity.

[25]  K. Kerr,et al.  Killing of Aspergillus fumigatus spores by human lung macrophages: a paradoxical effect of heat-labile serum components. , 1989, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[26]  M. Dinauer,et al.  Absence of Respiratory Burst in X-linked Chronic Granulomatous Disease Mice Leads to Abnormalities in Both Host Defense and Inflammatory Response to Aspergillus fumigatus , 1997, The Journal of experimental medicine.

[27]  W. Leisenring,et al.  Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. , 1997, The Journal of infectious diseases.

[28]  E. Michaliszyn,et al.  Lack of involvement of nitric oxide in killing of Aspergillus fumigatus conidia by pulmonary alveolar macrophages , 1995, Infection and immunity.

[29]  R. Amitani,et al.  Suppressive effects of Aspergillus fumigatus culture filtrates on human alveolar macrophages and polymorphonuclear leucocytes. , 1996, The European respiratory journal.

[30]  J. Steinkamp,et al.  Airway intra-luminal macrophages: evidence of origin and comparisons to alveolar macrophages. , 1990, American journal of respiratory cell and molecular biology.

[31]  T. Ganz,et al.  In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages. , 1986, The Journal of infectious diseases.

[32]  S. Bhakdi,et al.  Accumulation of Amphotericin B in Human Macrophages Enhances Activity against Aspergillus fumigatus Conidia: Quantification of Conidial Kill at the Single-Cell Level , 1998, Antimicrobial Agents and Chemotherapy.

[33]  Lawrence Corey,et al.  Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  J. Latgé,et al.  Cloning and disruption of the gene encoding an extracellular metalloprotease of Aspergillus fumigatus , 1994, Molecular microbiology.

[35]  K. Nomoto,et al.  The Role of Superoxide Anion and Lysosomal Enzymes in Anti‐Listerial Activity of Elicited Peritoneal Macrophages , 1986, Scandinavian journal of immunology.

[36]  S. Levitz,et al.  In vivo bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus. , 1984, The Journal of infectious diseases.